Notice of Registration - Importers
2019 - Cardinal Health
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances Registration
[Docket No. DEA-533]
ACTION: Notice of registration.
SUMMARY: The registrant listed below has applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The company listed below applied to be registered as an importer of various basic classes of schedule II controlled substances. Information on previously published notice is listed in the table below. No comments or objections were submitted and no requests for a hearing were submitted for this notice.
| Company | FR Docket | Published |
|---|---|---|
| Cardinal Health | 84 FR 35691 | July 24, 2019 |
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrant to import the applicable various basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule II controlled substance to the above listed company.
Dated: 10/23/2019
William T. McDermott,
Assistant Administrator.
